Insider Sale: CVP, JAPAC at EW sold 568 Shares

Markowitz Wayne, a CVP, JAPAC at Edwards Lifesciences (NYSE: EW), sold 568 shares of the company on Sep 14, 2026 for an estimated $47,922. This was a sale of approximately 2.8% of their shares of this class of stock. Following this trade, they now own 19,370 shares of this class of EW stock.

Edwards Lifesciences Insider Trading Activity

Edwards Lifesciences insiders have traded EW stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.

Here’s a breakdown of recent trading of EW stock by insiders over the last 6 months:

• BOBO DONALD E JR (CVP,Strategy/Corp Development) has made 0 purchases and 5 sales selling 63,793 shares for an estimated $5,290,927.
• Zovighian Bernard J (CEO) has made 0 purchases and 4 sales selling 39,795 shares for an estimated $3,124,129.
• Chopra Daveen (CVP, TMTT, Surgical & IHFM) has made 0 purchases and 3 sales selling 33,300 shares for an estimated $3,021,345.
• Ullem Scott B. (CVP, Chief Financial Officer) has made 0 purchases and 2 sales selling 13,000 shares for an estimated $1,040,544.
• Markowitz Wayne (CVP, JAPAC) has made 0 purchases and 4 sales selling 11,607 shares for an estimated $992,242.
• Lippis Daniel J. (CVP, TAVR) has made 0 purchases and 9 sales selling 6,153 shares for an estimated $527,464.
• Bruls Annette (CVP, EMEACLA) sold 2,644 shares for an estimated $237,907.
• Dahl Andrew M. (SVP, Corporate Controller) has made 0 purchases and 2 sales selling 1,112 shares for an estimated $98,387.

Edwards Lifesciences Revenue

Edwards Lifesciences had revenues of $3.39B in H1 2026. This represents a 15.10% increase from the same period last year.